Return On Equity of Matinas BioPharma Holdings, Inc. from 30 Sep 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Matinas BioPharma Holdings, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2014 to 30 Sep 2025.
  • Matinas BioPharma Holdings, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -241%, a 96% decline year-over-year.
  • Matinas BioPharma Holdings, Inc. annual Return On Equity for 2024 was -170%, a 91% decline from 2023.
  • Matinas BioPharma Holdings, Inc. annual Return On Equity for 2023 was -89%, a 76% decline from 2022.
  • Matinas BioPharma Holdings, Inc. annual Return On Equity for 2022 was -51%, a 31% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Matinas BioPharma Holdings, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -241% -118% -96% 01 Jul 2025 30 Sep 2025
Q2 2025 -210% -90% -74% 01 Apr 2025 30 Jun 2025
Q1 2025 -165% -55% -50% 01 Jan 2025 31 Mar 2025
Q4 2024 -170% -81% -91% 01 Oct 2024 31 Dec 2024
Q3 2024 -123% -52% -74% 01 Jul 2024 30 Sep 2024
Q2 2024 -120% -60% -98% 01 Apr 2024 30 Jun 2024
Q1 2024 -110% -55% -101% 01 Jan 2024 31 Mar 2024
Q4 2023 -89% -39% -76% 01 Oct 2023 31 Dec 2023
Q3 2023 -71% -18% -33% 01 Jul 2023 30 Sep 2023
Q2 2023 -61% -10% -20% 01 Apr 2023 30 Jun 2023
Q1 2023 -54% -11% -24% 01 Jan 2023 31 Mar 2023
Q4 2022 -51% -12% -31% 01 Oct 2022 31 Dec 2022
Q3 2022 -53% -17% -45% 01 Jul 2022 30 Sep 2022
Q2 2022 -51% -18% -53% 01 Apr 2022 30 Jun 2022
Q1 2022 -44% -11% -33% 01 Jan 2022 31 Mar 2022
Q4 2021 -39% -7% -22% 01 Oct 2021 31 Dec 2021
Q3 2021 -36% -2% -5.8% 01 Jul 2021 30 Sep 2021
Q2 2021 -33% +4.3% +12% 01 Apr 2021 30 Jun 2021
Q1 2021 -33% +5.9% +15% 01 Jan 2021 31 Mar 2021
Q4 2020 -32% +13% +29% 01 Oct 2020 31 Dec 2020
Q3 2020 -34% +10% +23% 01 Jul 2020 30 Sep 2020
Q2 2020 -37% +14% +27% 01 Apr 2020 30 Jun 2020
Q1 2020 -39% +30% +43% 01 Jan 2020 31 Mar 2020
Q4 2019 -45% +74% +62% 01 Oct 2019 31 Dec 2019
Q3 2019 -45% +89% +67% 01 Jul 2019 30 Sep 2019
Q2 2019 -51% +80% +61% 01 Apr 2019 30 Jun 2019
Q1 2019 -68% +60% +47% 01 Jan 2019 31 Mar 2019
Q4 2018 -119% -11% -10% 01 Oct 2018 31 Dec 2018
Q3 2018 -134% -32% -32% 01 Jul 2018 30 Sep 2018
Q2 2018 -131% -33% -34% 01 Apr 2018 30 Jun 2018
Q1 2018 -128% -24% -23% 01 Jan 2018 31 Mar 2018
Q4 2017 -108% +24% +18% 01 Oct 2017 31 Dec 2017
Q3 2017 -102% +38% +27% 01 Jul 2017 30 Sep 2017
Q2 2017 -98% +61% +38% 01 Apr 2017 30 Jun 2017
Q1 2017 -104% +32% +23% 01 Jan 2017 31 Mar 2017
Q4 2016 -132% -1.4% -1.1% 01 Oct 2016 31 Dec 2016
Q3 2016 -140% +28% +17% 01 Jul 2016 30 Sep 2016
Q2 2016 -159% +35% +18% 01 Apr 2016 30 Jun 2016
Q1 2016 -136% +79% +37% 01 Jan 2016 31 Mar 2016
Q4 2015 -130% +55% +30% 01 Oct 2015 31 Dec 2015
Q3 2015 -168% -50% -42% 01 Jul 2015 30 Sep 2015
Q2 2015 -193% 01 Apr 2015 30 Jun 2015
Q1 2015 -215% 01 Jan 2015 31 Mar 2015
Q4 2014 -185% 01 Oct 2014 31 Dec 2014
Q3 2014 -119% 01 Jul 2014 30 Sep 2014

Matinas BioPharma Holdings, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -170% -81% -91% 01 Jan 2024 31 Dec 2024
2023 -89% -39% -76% 01 Jan 2023 31 Dec 2023
2022 -51% -12% -31% 01 Jan 2022 31 Dec 2022
2021 -39% -7% -22% 01 Jan 2021 31 Dec 2021
2020 -32% +13% +29% 01 Jan 2020 31 Dec 2020
2019 -45% +74% +62% 01 Jan 2019 31 Dec 2019
2018 -119% -11% -10% 01 Jan 2018 31 Dec 2018
2017 -108% +24% +18% 01 Jan 2017 31 Dec 2017
2016 -132% -1.4% -1.1% 01 Jan 2016 31 Dec 2016
2015 -130% +55% +30% 01 Jan 2015 31 Dec 2015
2014 -185% 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.